Caspofungin Modulates Ryanodine Receptor-Mediated Calcium Release in Human Cardiac Myocytes-Reference-Cited by-同舟云学术

Caspofungin Modulates Ryanodine Receptor-Mediated Calcium Release in Human Cardiac Myocytes

Published:2018-11 Issue:11 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Koch Christian¹,Jersch Jennifer¹,Schneck Emmanuel¹,Edinger Fabian¹,Maxeiner Hagen¹,Uhle Florian²,Weigand Markus A.²,Markmann Melanie¹,Sander Michael¹,Henrich Michael³

Affiliation:

1. Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital of Giessen and Marburg, Giessen, Germany

2. Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany

3. Department of Anesthesiology, St. Vincentius Clinics, Karlsruhe, Germany

Abstract

Recent studies showed that critically ill patients might be at risk for hemodynamic impairment during caspofungin (CAS) therapy. The aim of our present study was to examine the mechanisms behind CAS-induced cardiac alterations.

Funder

Deutsches Zentrum für Infektionsforschung

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01114-18

Reference22 articles.

1. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

2. ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

3. Effects of echinocandin preparations on adult rat ventricular cardiomyocytes